Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Market Definitions
1.3 Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formtulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4 Research Scope and Assumptions
1.4.1 List To Data Sources
Chapter 2 Executive Summary
2.1 Market Snapshot 2022
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Biopharma Plastics Market: Variables and Trends
3.1 Market Lineage Outlook
3.1.1 Global Plastics Market
3.2 Biopharma Plastics Market- Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Raw Material Trends
3.3.1.1 Propylene
3.3.1.2 Ethylene Terephthalate
3.3.1.3 Ethylene
3.3.1.4 Vinyl Chloride
3.4 Technology Overview
3.4.1 Biopharma Plastics Market- Patent Analysis
3.5 Regulatory Framework
3.5.1 Standard & Compliances
3.5.1.1 Polyethylene (PE)
3.5.2 Safety
3.5.2.1 Polyethylene (PE)
3.5.2.2 Polypropylene (PP)
3.5.2.3 Acrylonitrile Butadiene Styrene (ABS)
3.5.2.4 First-Aid Measures
3.5.2.5 Polyvinyl Chloride
3.6 Market Dynamics
3.6.1 Market Driver Impact Analysis
3.6.1.1 Rise in global healthcare expenditure
3.6.1.2 Increasing cases of cancerous patients across the global
3.6.2 Market Restraint Impact Analysis
3.6.2.1 Volatile Raw Material Prices
3.6.3 Market Challenges Analysis
3.6.4 Market Opportunity Analysis
3.7 Impact of Russia & Ukraine Implication on Biopharma Plastics Market
3.8 Impact of COVID-19 on Biopharma Plastics Market
3.9 Industry Analysis Tools
3.9.1 Porter’s Analysis
3.9.2 Macroeconomic Analysis
Chapter 4 Biopharma Plastics Market: Polymer Type Estimates & Trend Analysis
4.1 Polymer Type Movement Analysis & Market Share, 2022 & 2030
4.2 Polymer Type Movement Analysis & Market Share, 2022 & 2030
4.3 Biopharma Plastics Market Estimates & Forecast, By Polymer Type (Kilotons) (USD Million)
4.3.1 Polyethylene (PE)
4.3.2 Polypropylene (PP)
4.3.3 Acrylonitrile Butadiene Styrene (ABS)
4.3.4 Polyethylene Terephthalate (PET)
4.3.5 Polyvinyl Chloride (PVC)
4.3.6 Polytetrafluoroethylene (PTFE)
4.3.7 Polycarbonate (PC)
4.3.8 Others
Chapter 5 Biopharma Plastics Market: Application Estimates & Trend Analysis
5.1 Application Movement Analysis & Market Share, 2022 & 2030
5.2 Application Movement Analysis & Market Share, 2022 & 2030
5.3 Biopharma Plastics Market Estimates & Forecast, By Application (Kilotons) (USD Million)
5.3.1 Protective Wear
5.3.2 Containers
5.3.3 Bioreactor Bags
5.3.4 Syringes
5.3.5 Depth Filters
5.3.6 Disposable Medical Connectors
5.3.7 Others
Chapter 6 Biopharma Plastics Market: Regional Estimates & Trend Analysis
6.1 Biopharma Plastics Market: Regional Outlook
6.2 North America
6.2.1 North America Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Biopharma Plastics Market estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.2.3 Canada
6.2.3.1 Canada Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.2.4 Mexico
6.2.4.1 Mexico Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.3 Europe
6.3.1 Europe Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.3.2 Germany
6.3.2.1 Germany Biopharma Plastics Market estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.3.3 France
6.3.3.1 France Biopharma Plastics Market estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.3.4 UK
6.3.4.1 UK Biopharma Plastics Market estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.3.5 Italy
6.3.5.1 Italy Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.4.2 China
6.4.2.1 China Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.4.3 India
6.4.3.1 India Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.4.4 Japan
6.4.4.1 japan Biopharma Plastics Market estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.5 Central & South America
6.5.1 Central & South America Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.5.3 Argentina
6.5.3.1 Argentina Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.6 Middle East & Africa
6.6.1 Middle East & Africa Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.6.2 Gcc Countries
6.6.2.1 Gcc Countries Biopharma Plastics Market Estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa Biopharma Plastics Market estimates & Forecasts, 2019 – 2030 (Kilotons) (USD Million)
Chapter 7 Biopharma Plastics Market – Competitive Landscape
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Categorization
7.3 Vendor Landscape
7.3.1 List Of Key Distributors & Channel Partners
7.3.2 List Of Key Potential Customers/End-Users
7.4 Participant’s Overview
7.5 Financial Performance
7.6 Product Benchmarking
7.7 Company Heat Map Analysis
7.8 Strategy Mapping
7.8.1 Expansion
7.8.2 Mergers & Acquisition
7.8.3 Collaboration
7.8.4 New Application Launches
7.8.5 Research & Developmet
7.9 Company Listing (Overview, Financials, Product Portfolio)
7.9.1 BASF SE
7.9.2 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
7.9.3 SABIC
7.9.4 LG CHEM
7.9.5 TORAY INDUSTRIES, INC.
7.9.6 SOLVAY
7.9.7 DOW, INC.
7.9.8 DUPONT DE NEMOURS, INC.
7.9.9 SAINT-GOBAIN PERFORMANCE PLASTICS
7.9.10 TEKNI-PLEX
7.9.11 CHEVRON PHILLIPS CHEMICAL CO., LLC
7.9.12 EXXON MOBIL CORPORATION
7.9.13 FORMOSA PLASTICS CORPORATION
7.9.14 COVESTRO AG
7.9.15 TEIJIN LIMITED
7.9.16 MITSUI & CO. PLASTICS LTD.
7.9.17 INEOS GROUP
7.9.18 CHIMEI